Form 4: Oxbridge Re Holdings CFO Timothy Wrendon Reports Share Transactions
SEC Form 4 Filing
Timothy Wrendon, CFO & Secretary of Oxbridge Re Holdings, reports acquisition and disposal of ordinary shares and share options.
Summary
- On February 14, 2025, Timothy Wrendon, CFO & Secretary of Oxbridge Re Holdings Ltd, reported transactions involving the company's ordinary shares and share options.
- Wrendon acquired 25,000 ordinary shares as a grant under the Issuer's 2021 Omnibus Incentive Plan at $0.
- He also executed a 'net exercise' of 90,000 share options at a price of $2, resulting in the acquisition of 90,000 ordinary shares.
- 35,020 shares were withheld by the company for payment of the exercise price at $5.14 per share.
- After these transactions, Wrendon beneficially owns 155,030 ordinary shares.
- Wrendon also holds various share options with different exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: Neutral sentiment as it is a standard regulatory filing detailing insider transactions. The transactions themselves don't necessarily indicate a positive or negative outlook.
Positives
- The grant of 25,000 restricted ordinary shares to the CFO indicates confidence in the company's future.
- The exercise of share options demonstrates the CFO's belief in the company's potential for growth.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.
Comparison to Industry Standards
- Monitoring insider transactions is a standard practice in corporate governance to ensure compliance with securities laws.
- Companies like RenaissanceRe (RNR) and Everest Re Group (RE) also have similar insider transaction reporting requirements.
- The frequency and nature of these transactions are typical for executives holding equity-based compensation.
Stakeholder Impact
- Shareholders may view this information to understand the actions of company leadership.
- The transactions have a minor impact on the overall share structure.
Key Dates
| Date | Description |
|---|---|
| 01/01/2023 | Start date for share options exercisable on a quarterly basis. |
| 01/16/2026 | Share options for 10,000 shares at $6 exercisable. |
| 01/20/2027 | Share options for 10,000 shares at $6.06 exercisable. |
| 03/26/2029 | Warrants to purchase 7,500 ordinary shares at $7.5 exercisable. |
| 03/16/2029 | Expiration date for share options. |
| 03/02/2031 | Share options for 75,000 shares at $6 exercisable. |
| 02/14/2025 | Date of reported transactions: grant of shares and exercise of options. |
| 02/20/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.